Bioavailability, Biopotency and Food Effect Study of SCD0503 Compared to Subcutaneous Regular Human Insulin

NCT07634770 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: oral insulin
OTHER: Placebo A
BIOLOGICAL: subcutaneous insulin
OTHER: Placebo B

Sponsor

Sam Chun Dang Pharm. Co. Ltd.

Collaborators

[object Object]